SUrgical Versus PERcutaneous AXillary Artery International Registry

Inclusion Criteria: * Patients who received a surgical or percutaneous access to the axillary or brachial artery during Transcatheter Aortic Valve Implantation (TAVI), Fenestrated/Branched-Endovascular Aortic Repair (F/BEVAR), chimney-EVAR (Ch-EVAR) or visceral side branches stenting, between January 2010 and May 2020 * Adult patients ≥18 years Exclusion Criteria: * Introducer sheath internal diameter (ID) used \< 5F or \> 22F * Patient with previous surgical axillary access on the puncture side (Pacemaker excluded) * Patient with subclavian / axillary / brachial occlusive disease with stenosis greater than 50% * Patient with previous bypass surgery or stent placement in the vicinity of access site (ie. Axillary extracorporeal cannulation with, axillo-femoral bypass, patch (venous or synthetic repair of previous axillary access, etc) * Bleeding diathesis or coagulopathy * Patients with active systemic or cutaneous infection or inflammation * Patients who are pregnant or lactating * Patient younger than 18 years of age * Patients who are morbidity obese (BMI \> 40 Kg/m2)